In this study investigation of plasmid-mediated mcr 1-5 resistance genes was performed among multidrug-resistant (MDR) colistin sensitive and resistant Klebsiella pneumoniae and Escherichia coli strains isolated in our laboratory. We aimed to evaluate automated system (Vitek-2), broth microdilution (BMD) reference method and chromogenic media performance. Totally 94 MDR K. pneumoniae and six E. coli isolates were included in the study. CHROMID® Colistin R agar (COLR) (bioMerieux, France) was used to determine the colistin resistance by chromogenic method. Standard PCR amplification was performed using specific primers to screen the plasmid-mediated mcr 1-5 genes. Sixty-one isolates were resistant to colistin and 39 were susceptible with reference BMD. The essential and categorical agreement of Vitek-2 was determined as 100 and 99%. The sensitivity of COLR medium was 100%, the specificity was 97.5%. In our study mcr-1 was detected in eight isolates, while other mcr genes were not detected. Due to the high sensitivity and specificity of the COLR medium, it can be used in routine diagnostics for the detection of colistin resistance. In our study we detected 8% prevalence of mcr-1 among MDR strains however, two mcr-1 positive isolates were found sensitive to colistin by BMD.
Aghapour Z, Gholizadeh P, Ganbarov K, Bialvaei AZ, Mahmood SS, Tanomand A, . Molecular mechanisms related to colistin resistance in Enterobacteriaceae. Infect Drug Resist 2019; 12: 965–75.
Poirel L, Jayol A, Nordmann P. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev 2017; 30: 557–96.
The detection and reporting of colistin resistance. Geneva: World Health Organization; (WHO reference number) Licence: CC BY-NC-SA 3.0 IGO; 2018.
Bardet L, Rolain JM. Development of new tools to detect colistin-resistance among Enterobacteriaceae strains. Can J Infect Dis Med Microbiol 2018; 2018: 3095249.
The European Committee on Antimicrobial Susceptibility Testing – MIC and zone diameter distributions and ECOFFs. EUCAST; V.10.0; 2020.
ISO 20776-1. Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — Part 1: broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases; 2019.
Rojas LJ, Salim M, Cober E, Richter SS, Perez F, Salata RA, . Colistin resistance in carbapenem-resistant Klebsiella pneumoniae: laboratory detection and impact on mortality. Clin Infect Dis 2017; 64: 711–18.
De Kraker ME, Stewardson AJ, Harbarth S. Will 10 million people die a year due to antimicrobial resistance by 2050? Plos Med 2016; 13: e1002184.
García-Fernández S, García-Castillo M, Ruiz-Garbajosa P, Morosini MI, Bala Y, Zambardi G, Cantón R. Performance of CHROMID® Colistin R agar, a new chromogenic medium for screening of colistin-resistant Enterobacterales. Diagn Microbiol Infect Dis 2019; 93: 1–4.
Girlich D, Naas T, Dortet L. Comparison of the superpolymyxin and ChromID colistin R screening media for the detection of colistin-resistant Enterobacteriaceae from spiked rectal swabs. Antimicrob Agents Chemother 2018; 63: e01618–18.
Roche JM, Basso E, Zambardi G. Early detection of colistin-resistant Gram-negative bacteria using chromID colistin R agar, a new chromogenic medium 27. ECCMID Vienna Austria 22-25.04; 2017, P0684.
Pfennigwerth N, Kaminski A, Korte-Berwanger M, Pfeifer Y, Simon M, Werner G, . Evaluation of six commercial products for colistin susceptibility testing in Enterobacterales. Clin Microbiol Infect 2019; 25: 1385–9.
Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, . Emergence of plasmid-mediated colistin resistance mechanism mcr-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 2016; 16: 161–8.
Mendelson M, Brink A, Gouws J, Mbelle N, Naidoo V, Pople T, . The one health stewardship of colistin as an antibiotic of last resort for human health in South Africa. Lancet Infect Dis 2018; 18: e288–94.
Sarı AN, Süzük S, Karatuna O, Öğünç D, Karakoç AE, Çizmeci Z, . Results of a multicenter study investigating plasmid mediated colistin resistance genes (mcr-1 and mcr-2) in clinical Enterobacteriaceae isolates from Turkey. Mikrobiyol Bul 2017; 51: 299–303.
Srijan A, Margulieux KR, Ruekit S, Snesrud E, Maybank R, Serichantalergs O, . Genomic characterization of nonclonal mcr-1-positive multidrug-resistant Klebsiella pneumoniae from clinical samples in Thailand. Microb Drug Resist 2018; 24: 403–10.
Zaki MS, Elkheir NA, Mofreh M. Molecular study of colistin resistant clinical isolates of Enterobacteriaceae species. J Clin Mol Med 2018; 1: 1–4.
Xavier BB, Lammens C, Ruhal R, Kumar-Singh S, Butaye P, Goossens H, . Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli. Euro Surveill 2016; 21.
Özhelvacı Y. Investigation of existance of plasmid-mediated (mcr-1, mcr-2) and chromosomal colistin resistance genes (phop/phoq, pmra/pmrb) in members of enterobacteriaceae. Afyonkarahisar University of Health Sciences, Thesis; 2019.
Liassine N, Assouvie L, Descombes MC, Tendon VD, Kieffer N, Poirel L, . Very low prevalence of mcr-1/mcr-2 plasmid-mediated colistin resistance in urinary tract Enterobacteriaceae in Switzerland. Int J Infect Dis 2016; 51: 4–5.
Zhong YM, Liu WE, Zheng ZF. Epidemiology and molecular characterization of mcr-1 in Escherichia coli recovered from patients with bloodstream infections in Changsha, central China. Infect Drug Resist 2019; 12: 2069–76.
Quan J, Li X, Chen Y, Jiang Y, Zhou Z, Zhang H, . Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study. Lancet Infect Dis 2017; 17: 400–10.
Arabacı Ç, Dal T, Başyiğit T, Genişel N, Durmaz R. Investigation of carbapenemase and mcr-1 genes in carbapenem-resistant Klebsiella pneumoniae isolates. J Infect Dev Ctries 2019; 13: 504–9.
Lee YL, Lu MC, Shao PL, Lee YL, Lu MC, Shao PL, . Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018. Int J Antimicrob Agents 2019; 54: 318–28.
Zhang J, Chen L, Wang J, Butaye P, Huang K, Qiu H, . Molecular detection of colistin resistance genes (mcr-1 to mcr-5) in human vaginal swabs. BMC Res Notes 2018; 11: 143.
Huang H, Dong N, Shu L, Sun Q, Chan EW, Chen S, . Colistin-resistance gene mcr in clinical carbapenem-resistant Enterobacteriaceae strains in China, 2014–2019. Emerg Microbes Infect 2020; 9: 237–45.